Percutaneus Thermoablation in Patients with Primary and Secondary Liver Cancer - Early Results

• Authors: Dariusz Zadrożny , Zbigniew Śledziński , Michał Studniarek , Sebastian Dobrowolski , Tomasz Gorycki , Walenty Adamonis , Kamil Bury
• Languages of publication: EN

Abstracts

EN

Liver is common place where the cancer occurs primary as well as secondary. Liver resection as a potentially healing method can be performed only in about 20% of patients. Prognosis in group of patients treated non-invasively is bad. Using high frequency thermal ablation which damages the neoplastic tissue in liver may lead to prolongation of life expectancy.The aim of the study was to assess the early results of using the high frequency thermal ablation in patients with primary or secondary cancer.Material and methods. During years of 2001-2007 371 patients underwent the 520 procedures of percutaneous RF thermal ablation under US control. Mean age of patients was 62.47 (19-85 ± 11.63). 175 women and 196 men were treated using this method.Results. There were 10 early complications after thermal ablation (1.92% of procedures, 2.7% of patients). Two of them ended fatal (0.38% of procedures, 0.54% of patients). In seven cases absces formation were observed, one of them was the cause of death due to Clostridium perfingens infection. Cholerrhagia from damaged bile duct in cirrhotic liver caused the peritonitis and subsequent death of patient. Two patients suffered from sub-capsular hematoma of liver. 14 patients also suffered from long lasting pain (more than 14 days).Conclusions. Percutaneous thermal ablation in primary or secondary liver tumors is safe and efficient procedure. Long term follow up will give the knowledge about the real value of the procedure.

Keywords

EN

thermal ablation; liver tumor; liver metastasis

• Publisher: Index Copernicus International
• Journal: Polish Journal of Surgery
• Year: 2008
• Volume: 80
• Issue: 8
• Pages: 387-393

Dates

published

1 - 8 - 2008

online

10 - 9 - 2008

Contributors

author

Dariusz Zadrożny

• Department of General, Endocrine and Transplant Surgery, Medical University, Gdańsk

author

Zbigniew Śledziński

• Department of General, Endocrine and Transplant Surgery, Medical University, Gdańsk

author

Michał Studniarek

• Department of Radiology, Medical University, Gdańsk

author

Sebastian Dobrowolski

• Department of General, Endocrine and Transplant Surgery, Medical University, Gdańsk

author

Tomasz Gorycki

• Department of Radiology, Medical University, Gdańsk

author

Walenty Adamonis

• Department of General, Endocrine and Transplant Surgery, Medical University, Gdańsk

author

Kamil Bury

• Department of General, Endocrine and Transplant Surgery, Medical University, Gdańsk

References

• Bruix J, Sherman M, Llovet JM et al.: Clinical management of hepatocellular carcinoma. Conclusions of the Barcelona-2000 EASL conference. European Association for the Study of the Liver. J Hepatol 2001; 35: 421-30.[Crossref]
• Greenlee RT, Hill-Harmon MB, Murray T et al.: Cancer statistics 2001. CA Cancer J Clin 2001; 51: 15-36.
• Landis SH, Murray T, Bolden S et al.: Cancer statistics, 1999. CA Cancer J Clin 1999; 49: 8-31.[Crossref]
• El-Serag HB: Hepatocellular carcinoma: recent trends in the United States. Gastroenterology 2004; 127: 27-34.
• Giovannini M: Percutaneous alcohol ablation for liver metastasis. Semin Oncol 2002; 29: 192-95.[PubMed][Crossref]
• Morris DL: Ablative therapy for liver cancer: which? Ann Surg Oncol 2005; 12: 205-06.[Crossref][PubMed]
• Feliberti EC, Wagman LD: Radiofrequency ablation of liver metastases from colorectal carcinoma. Cancer Control 2006; 13: 48-51.[PubMed]
• Siewert JR: Lebermetastasen - ein lokoregionales Problem? Chirurg 1999; 70: 113.[Crossref]
• Bageacu S, Kaczmarek D, Lacroix M et al.: Cryosurgery for resectable and unresectable hepatic metastases from colorectal cancer. Eur J Surg Oncol 2007; 33: 590-96.[Crossref][WoS]
• Sheen AJ, Siriwardena AK: The end of cryotherapy for the treatment of nonresectable hepatic tumors? Ann Surg Oncol 2005; 12: 202-04.[Crossref][PubMed]
• Fontana RJ, Hamidullah H, Nghiem H et al.: Percutaneous radiofrequency thermal ablation of hepatocellular carcinoma: a safe and effective bridge to liver transplantation. Liver Transpl 2002; 8: 1165-74.[Crossref]
• Abu Hilal M, Lodge JP: Pushing back the frontiers of resectability in liver cancer surgery. Eur J Surg Oncol 2007 (in press).[WoS]
• Gruenberger T, Jourdan JL, Zhao J et al.: Reduction in recurrence risk for involved or inadequate margins with edge cryotherapy after liver resection for colorectal metastases. Arch Surg 2001; 136: 1154-57.
• Weber SM, Lee FT: Expanded treatment of hepatic tumors with radiofrequency ablation and cryoablation. Oncology 2005; 19: 27-32.
• Dodd GD, Soulen MC, Kane RA: Minimally invasive treatment of malignant hepatic tumors: at the threshold of a major breakthrough. Radiographics 2000; 20: 9-27.[Crossref]
• Vogl TJ, Straub R, Zangos S et al.: MR-guided laser induced thermotherapy (LITT) of liver tumours: experimental and clinical data. Int J Hyperthermia 2004; 20: 713-24.[Crossref]
• Curley SA, Marra P, Beaty K et al.: Early and late complications after radiofrequency ablation of malignant liver tumors in 608 patients. Ann Surg 2004; 239: 450-58.
• Mulier S, Mulier P, Ni Y et al.: Complications of radiofrequency coagulation of liver tumours. Br J Surg 2002; 89: 1206-22.[Crossref]
• Wood TF, Rose DM, Chung M et al.: Radiofrequency ablation of 231 unresectable hepatic tumors: indications, limitations, and complications. Ann Surg Oncol 2000; 7: 593-600.
• Zagoria RJ, Chen MY, Shen P et al.: Complications from radiofrequency ablation of liver metastases. Am Surg 2002; 68: 204-09.
• Bilchik AJ, Wood TF, Allegra DP: Radiofrequency ablation of unresectable hepatic malignancies: lessons learned. Oncologist 2001; 6: 24-33.[Crossref][PubMed]
• De Baere T, Risse O, Kuoch V et al.: Adverse events during radiofrequency treatment of 582 hepatic tumors. AJR Am J Roentgenol 2003; 181: 695-700.
• Pereira PL: Actual role of radiofrequency ablation of liver metastases. Eur Radiol 2007; 17: 2062-70.[WoS][PubMed][Crossref]
• Feliberti EC, Wagman LD: Radiofrequency ablation of liver metastases from colorectal carcinoma. Cancer Control 2006; 13: 48-51.[PubMed]
• Joosten J, Jager G, Oyen W et al.: Cryosurgery and radiofrequency ablation for unresectable colorectal liver metastases. Eur J Surg Oncol 2005; 31: 1152-59.[Crossref]
• Lochan R, White SA, Manas DM: Liver resection for colorectal liver metastasis. Surg Oncol 2007; 16: 33-45.[Crossref][PubMed]
• Mazzaferro V, Regalia E, Doci R et al.: Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis. N Engl J Med 1996; 334: 693-99.
• Scheele J, Stangl R, Altendorf-Hofmann A et al.: Indicators of prognosis after hepatic resection for colorectal secondaries. Surgery 1991; 110: 13-29.
• Wright AS, Mahvi DM, Haemmerich DG et al.: Minimally invasive approaches in management of hepatic tumors. Surg Technol Int 2003; 11: 144-53.

Identifiers

DOI

10.2478/v10035-008-0055-9